| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |